Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 2
1996 1
1997 3
1998 3
1999 7
2000 3
2001 9
2002 10
2003 11
2004 10
2005 9
2006 10
2007 9
2008 18
2009 20
2010 22
2011 12
2012 7
2013 16
2014 4
2015 15
2016 13
2017 10
2018 4
2019 7
2020 11
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

235 results
Results by year
Filters applied: . Clear all
Page 1
Platinum-based chemotherapy for variant castrate-resistant prostate cancer.
Aparicio AM, Harzstark AL, Corn PG, Wen S, Araujo JC, Tu SM, Pagliaro LC, Kim J, Millikan RE, Ryan C, Tannir NM, Zurita AJ, Mathew P, Arap W, Troncoso P, Thall PF, Logothetis CJ. Aparicio AM, et al. Among authors: arap w. Clin Cancer Res. 2013 Jul 1;19(13):3621-30. doi: 10.1158/1078-0432.CCR-12-3791. Epub 2013 May 6. Clin Cancer Res. 2013. PMID: 23649003 Free PMC article.
Prostate Cancer Progression and the Epigenome.
Arap W, Pasqualini R, Costello JF. Arap W, et al. N Engl J Med. 2020 Dec 3;383(23):2287-2290. doi: 10.1056/NEJMcibr2030475. N Engl J Med. 2020. PMID: 33264551 No abstract available.
Eph receptors as cancer targets for antibody-based therapy.
Tang FHF, Davis D, Arap W, Pasqualini R, Staquicini FI. Tang FHF, et al. Among authors: arap w. Adv Cancer Res. 2020;147:303-317. doi: 10.1016/bs.acr.2020.04.007. Epub 2020 Jun 12. Adv Cancer Res. 2020. PMID: 32593404 Review.
Does the RAAS play a role in loss of taste and smell during COVID-19 infections?
Luchiari HR, Giordano RJ, Sidman RL, Pasqualini R, Arap W. Luchiari HR, et al. Among authors: arap w. Pharmacogenomics J. 2021 Apr;21(2):109-115. doi: 10.1038/s41397-020-00202-8. Epub 2020 Dec 15. Pharmacogenomics J. 2021. PMID: 33323946 Free PMC article. Review. No abstract available.
The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injury.
Lebeau PF, Wassef H, Byun JH, Platko K, Ason B, Jackson S, Dobroff J, Shetterly S, Richards WG, Al-Hashimi AA, Won KD, Mbikay M, Prat A, Tang A, Paré G, Pasqualini R, Seidah NG, Arap W, Chrétien M, Austin RC. Lebeau PF, et al. Among authors: arap w. J Clin Invest. 2021 Jan 19;131(2):e128650. doi: 10.1172/JCI128650. J Clin Invest. 2021. PMID: 33211673 Free PMC article.
Ligand-targeted theranostic nanomedicines against cancer.
Yao VJ, D'Angelo S, Butler KS, Theron C, Smith TL, Marchiò S, Gelovani JG, Sidman RL, Dobroff AS, Brinker CJ, Bradbury ARM, Arap W, Pasqualini R. Yao VJ, et al. Among authors: arap w. J Control Release. 2016 Oct 28;240:267-286. doi: 10.1016/j.jconrel.2016.01.002. Epub 2016 Jan 6. J Control Release. 2016. PMID: 26772878 Free PMC article. Review.
Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer.
Suwan K, Yata T, Waramit S, Przystal JM, Stoneham CA, Bentayebi K, Asavarut P, Chongchai A, Pothachareon P, Lee KY, Topanurak S, Smith TL, Gelovani JG, Sidman RL, Pasqualini R, Arap W, Hajitou A. Suwan K, et al. Among authors: arap w. Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18571-18577. doi: 10.1073/pnas.1906653116. Epub 2019 Aug 2. Proc Natl Acad Sci U S A. 2019. PMID: 31375630 Free PMC article.
235 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page